Reprogrammed Astrocytes as a Potential Therapy for Neurodegenerative Disorders.
Year: 2011
Type: article
Abstract: We sought to determine which parental cell type was best suited for creating reprogrammed induced pluripotent stem cells (iPSCs) and what differences might exist between iPSCs generated from various tissues. To do this, we reprogrammed primary mouse astrocytes, a central nervous system derived cell, into astrocyte-derived iPSCs (mAsiPSCs) using an ectopic expression of Oct3/4, Sox2, Klf4 and c-Myc. These mAsiPSCs expressed stem cell markers and formed teratomas. Importantly, mAsiPSCs grew more slowly and were more likely to differentiate into neuronal-type cells compared to mouse embryonic fibroblast-derived iPSCs (MEFsiPSCs), a non-central nervous system-derived cell type. These results suggest that mAsiPSCs retain a “memory” of their central nervous system origin and may have a higher incidence of neuronal differentiation. Moreover, direct conversion of somatic cells into lineage-specific progenitor cells in one step, bypassing the intermediated pluripotent stage, provides an alternative strategy for generating promising cell types. We demonstrated the conversion of adult dermal fibroblasts into induced neural progenitor cells (iNPCs) using a novel combination of genes different from those previously reported. These iNPCs exhibit typical NPC morphology and marker gene expression, and a normal capacity for proliferation, self-renewal, and differentiation. Our findings suggest new cell-replacement strategies that may be beneficial for studies involving neurodegenerative diseases, disease modeling, and neural development.
Source: PubMed
Authors: Changhai Tian, Jialin C Zheng
Institution: University of Nebraska Medical Center
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W1814390881
